Emcure Pharmaceuticals Ltd
NSE:EMCURE
Cash Flow Statement
Cash Flow Statement
Emcure Pharmaceuticals Ltd
Sep-2024 | ||
---|---|---|
Operating Cash Flow | ||
Net Income |
8 187
|
|
Depreciation & Amortization |
3 654
|
|
Other Non-Cash Items |
2 320
|
|
Cash Taxes Paid |
2 604
|
|
Cash Interest Paid |
1 959
|
|
Change in Working Capital |
(5 130)
|
|
Cash from Operating Activities |
9 032
N/A
|
|
Investing Cash Flow | ||
Capital Expenditures |
(3 411)
|
|
Other Items |
(1 215)
|
|
Cash from Investing Activities |
(4 626)
N/A
|
|
Financing Cash Flow | ||
Net Issuance of Common Stock |
7 526
|
|
Net Issuance of Debt |
(5 814)
|
|
Other |
(2 382)
|
|
Cash from Financing Activities |
(670)
N/A
|
|
Change in Cash | ||
Effect of Foreign Exchange Rates |
(19)
|
|
Net Change in Cash |
3 717
N/A
|
|
Free Cash Flow | ||
Free Cash Flow |
5 621
N/A
|